SCHEMBL18088136

SCHEMBL18088136

CCOC(=O)COc1ccc(Nc2nc(C)nc3ccccc23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.59
MAPT P10636 11/20 0.57
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
NPSR1 Q6W5P4 4/20 0.57
GAA P10253 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPY1R P25929 1/20 0.57
NPY2R P49146 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
GPR55 Q9Y2T6 1/20 0.57
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 5/20 0.55
HPGD P15428 3/20 0.55
POLB P06746 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18088085 0.89 TP53 (0.57) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL18088012 0.88 TP53 (0.56) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL18087996 0.87 TP53 (0.55) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL18088102 0.86 TP53 (0.54) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL3114887 0.86 KMT2A (0.67) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL18088077 0.85 HDAC1 (0.64) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL20042056 0.83 ABCG2 (0.53) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL24653613 0.81 MAPT (0.54) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL19789212 0.81 TP53 (0.52) TP53MAPTKMT2AMEN1NPSR1
SCHEMBL28561652 0.80 HDAC1 (0.52) TP53MAPTKMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428705-B Histone deacetylase inhibitor and preparation method and application thereof 广东众生药业股份有限公司 2021-03-16 CN disclosed
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-04-12 US disclosed
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-04-12 US disclosed
WO-2016146074-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF 广东众生药业股份有限公司 2016-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF HDAC1, HDAC5, HDAC9 TP53 2767/4885MAPT 3211/4885KMT2A 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.